CLINICAL EVALUATION OF SIDDHA MEDICINE ARPUTHA MATHIRAI FOR THE MANAGEMENT OF SOOTHAGA VAAYU ( PCOS)
Phase 2
- Conditions
- Health Condition 1: E282- Polycystic ovarian syndrome
- Registration Number
- CTRI/2022/11/047285
- Lead Sponsor
- Dr Dowlathunnissa Begum G
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Married / Unmarried women aged between 15-40 years, Polycystic ovary in ultra sound (unilateral/bilateral). Amenorrhoea, Married women with primary infertility, Irregular menstruation, Ovulation related infertility, Oligomenorrhoea, All above criteria with or without hypothyroidism.
Exclusion Criteria
Hyperthyroidism, Congenital uterine defects, Pituitary/Adrenal disorders, Hemorrhagic cyst / Chocolate Cyst, Any serious systemic illness, Tuberculosis of the ovary and uterus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disappearance / Reduction in the size or number of cysts in ultra sound, ovulation or regulation of menstrual and hormonal profile. Any one or more among the above in a period of 2 or 3 weeks or more during the course of the study will be considered as primary outcome.Timepoint: The outcomes will be assessed after a period of 48 days.
- Secondary Outcome Measures
Name Time Method 1.Safety and efficacy of the drug will be assessed during the course of the study. <br/ ><br>Timepoint: Safety and efficacy will be assessed in a time period of 48 days.